enVVeno Medical (NVNO) Long-Term Deferred Tax (2020 - 2021)
enVVeno Medical's (NVNO) quarterly Long-Term Deferred Tax came in at $14.3 million in Q4 2021, up 33.62% year-on-year from $10.7 million in Q4 2020, and up 33.62% quarter-over-quarter from $10.7 million in Q4 2020.
enVVeno Medical (NVNO) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends
enVVeno Medical's Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $14.3 million for Q4 2021.
- On a quarterly basis, Long-Term Deferred Tax rose 33.62% year-over-year to $14.3 million in Q4 2021; TTM through Dec 2021 was $14.3 million, a 33.62% increase from a year earlier, with the FY2021 full-year figure at $14.3 million, up 33.62% from the prior year.
- Long-Term Deferred Tax climbed to $14.3 million in Q4 2021 per NVNO's latest filing, from $10.7 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $14.3 million in Q4 2021 and bottomed at $10.7 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | enVVeno Medical | 2.75 Mn | 2.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 14.31 Mn |
| Dec 31, 2020 | 10.71 Mn |